These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1421174

  • 1. Gene analyses of abnormal fibrinogens with a mutation in the gamma chain.
    Mimuro J, Muramatsu S, Maekawa H, Sakata Y, Kaneko M, Yoshitake S, Okuma M, Ito Y, Takeda Y, Matsuda M.
    Int J Hematol; 1992 Oct; 56(2):129-34. PubMed ID: 1421174
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
    Terasawa F, Okumura N, Higuchi Y, Ishikawa S, Tozuka M, Ishida F, Kitano K, Katsuyama T.
    Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
    [Abstract] [Full Text] [Related]

  • 4. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
    Lounes KC, Soria C, Valognes A, Turchini MF, Soria J, Koopman J.
    Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
    [Abstract] [Full Text] [Related]

  • 5. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N, Furihata K, Terasawa F, Nakagoshi R, Ueno I, Katsuyama T.
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [Abstract] [Full Text] [Related]

  • 6. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.
    Rosenberg JB, Newman PJ, Mosesson MW, Guillin MC, Amrani DL.
    Thromb Haemost; 1993 Mar 01; 69(3):217-20. PubMed ID: 8470043
    [Abstract] [Full Text] [Related]

  • 7. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H, Le Querrec A, de Moerloose P, Gandon-Laloum S, Borel Derlon A, Neerman-Arbez M.
    Blood Coagul Fibrinolysis; 2008 Oct 01; 19(7):697-9. PubMed ID: 18832913
    [Abstract] [Full Text] [Related]

  • 8. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P, Boyer-Neumann C, Haverkate F, Grimbergen J, Larrieu MJ, Anglés-Cano E.
    Blood Coagul Fibrinolysis; 1993 Oct 01; 4(5):679-87. PubMed ID: 8292717
    [Abstract] [Full Text] [Related]

  • 9. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
    Meyer M, Bergmann F, Brennan SO.
    Blood Coagul Fibrinolysis; 2006 Jan 01; 17(1):63-7. PubMed ID: 16607083
    [Abstract] [Full Text] [Related]

  • 10. Fibrinogen anomalies and disease. A clinical update.
    Galanakis DK.
    Hematol Oncol Clin North Am; 1992 Oct 01; 6(5):1171-87. PubMed ID: 1400080
    [Abstract] [Full Text] [Related]

  • 11. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
    Mathonnet F, Guillon L, Detruit H, Mazmanian GM, Dreyfus M, Alvarez JC, Giudicelli Y, de Mazancourt P.
    Blood Coagul Fibrinolysis; 2003 Apr 01; 14(3):293-8. PubMed ID: 12695754
    [Abstract] [Full Text] [Related]

  • 12. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M, Stucki B, Steinmann C, Jungo M, Lämmle B.
    Thromb Haemost; 1996 Sep 01; 76(3):377-83. PubMed ID: 8883274
    [Abstract] [Full Text] [Related]

  • 13. A new type of Ser substitution for gamma Arg-275 in fibrinogen Kamogawa I characterized by impaired fibrin assembly.
    Mimuro J, Kawata Y, Niwa K, Muramatsu S, Madoiwa S, Takano H, Sugo T, Sakata Y, Sugimoto T, Nose K, Matsuda M.
    Thromb Haemost; 1999 Jun 01; 81(6):940-4. PubMed ID: 10404772
    [Abstract] [Full Text] [Related]

  • 14. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
    Iida H, Ishii E, Nakahara M, Urata M, Wakiyama M, Kurihara M, Watanabe K, Kai T, Ihara K, Kinoshita S, Hamasaki N.
    Thromb Haemost; 2000 Jul 01; 84(1):49-53. PubMed ID: 10928469
    [Abstract] [Full Text] [Related]

  • 15. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
    Koopman J, Haverkate F, Briët E, Lord ST.
    J Biol Chem; 1991 Jul 15; 266(20):13456-61. PubMed ID: 2071611
    [Abstract] [Full Text] [Related]

  • 16. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K, Mimuro J, Miyata M, Sugo T, Ohmori T, Madoiwa S, Tei C, Sakata Y.
    Thromb Res; 2008 Jul 15; 121(6):773-80. PubMed ID: 17854865
    [Abstract] [Full Text] [Related]

  • 17. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
    Lounes KC, Lefkowitz JB, Coates AI, Hantgan RR, Henschen-Edman A, Lord ST.
    Ann N Y Acad Sci; 2001 Jul 15; 936():129-32. PubMed ID: 11460470
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
    Steinmann C, Bögli C, Jungo M, Lämmle B, Heinemann G, Wermuth B, Redaelli R, Baudo F, Furlan M.
    Blood Coagul Fibrinolysis; 1994 Aug 15; 5(4):463-71. PubMed ID: 7841300
    [Abstract] [Full Text] [Related]

  • 19. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N.
    Thromb Haemost; 2001 Jan 15; 85(1):108-13. PubMed ID: 11204560
    [Abstract] [Full Text] [Related]

  • 20. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
    Yoshida N, Imaoka S, Hirata H, Matsuda M, Asakura S.
    Thromb Haemost; 1992 Nov 10; 68(5):534-8. PubMed ID: 1455400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.